Botulinum Toxin
Botulinum toxin (BoNT) is a neurotoxin produced by the bacterium Clostridium botulinum. In aesthetic dermatology it is a gold-standard treatment for softening dynamic wrinkles, reducing enlarged muscles (masseter, trapezius, calf) and controlling excessive sweating (hyperhidrosis). By temporarily blocking the release of the neurotransmitter acetylcholine at the neuromuscular junction, it relaxes the target muscle without permanently damaging the nerve or the muscle tissue.
At Haute-Derma, botulinum toxin injections are planned around a detailed understanding of dynamic facial anatomy. Careful calculation of the dose in units, the injection depth and the toxin's spread radius lets us optimize results, keep facial expressions natural, and minimize the risk of complications such as a drooping eyelid or an uneven smile.
Pharmacology and Mechanism of Neuromuscular Blockade
Botulinum toxin serotype A (BoNT-A), the form most widely used in aesthetic medicine, works in four sequential steps:
- Selective binding and endocytosis: The toxin's 100 kDa heavy chain binds specifically to ganglioside and SV2 (synaptic vesicle protein 2) receptors on the presynaptic membrane of motor nerve endings. The complex is then taken into the cell inside an endocytic vesicle.
- SNARE cleavage: The 50 kDa light chain, a zinc endopeptidase, escapes from the vesicle into the cytoplasm and cleaves SNAP-25 (synaptosomal-associated protein, 25 kDa), a core component of the SNARE complex.
- Blocked acetylcholine release: Without intact SNAP-25, acetylcholine vesicles cannot fuse with the presynaptic membrane, so acetylcholine release into the synaptic cleft stops. The target muscle no longer receives the signal to contract and relaxes temporarily.
- Restored nerve transmission (sprouting and reinnervation): The effect lasts 3–6 months. Over that time the nerve terminal grows tiny new branches (axonal sprouting) that form new synaptic contacts, and normal muscle contraction returns.
Standard Botulinum Toxin Type A Products
| Product / Brand | Diffusion | Preferred Uses at Haute-Derma |
|---|---|---|
| OnabotulinumtoxinA (Botox / Allergan) | Moderate, precisely controlled | Dynamic wrinkles (frown lines, forehead, crow's feet), masseter slimming |
| AbobotulinumtoxinA (Dysport / Ipsen) | Wide, even spread | Large treatment areas (underarm/palm sweating, shoulder/calf contouring) |
| IncobotulinumtoxinA (Xeomin / Merz) | Moderate | Patients receiving repeated treatments, to limit the risk of toxin resistance |
| PrabotulinumtoxinA (Jeuveau / Nabota) | Moderate | Dynamic wrinkle rejuvenation and jawline slimming for younger clients |
Clinical Workflow and Anatomical Injection Technique at Haute-Derma
- Dynamic anatomical analysis and muscle strength assessment: The doctor asks the patient to make maximal expressions (raising the brows, frowning, squinting, clenching the teeth) to pinpoint the muscle bellies, the range of contraction and any left-right asymmetry.
- Layered injection technique by target area
- Forehead (frontalis): superficial subcutaneous injections at low doses (1–2 U per point), staying at least 1.5–2.0 cm above the orbital rim to avoid eyelid ptosis.
- Frown lines (corrugator and procerus): deep injection close to the bone at the medial head of the corrugator, where the muscle is strongest, and superficial subcutaneous injection at its lateral tail to keep the toxin from spreading into the levator palpebrae superioris.
- Jawline slimming (masseter): the safety zone lies below the line from the corner of the mouth to the earlobe. Three to five deep injections close to the bone reduce masseter hypertrophy without affecting the risorius (smile muscle).
- Micro-Botox / Mesobotox: highly diluted toxin injected as micro-droplets into the superficial dermis to reduce oil production, tighten the look of pores and smooth skin texture.
- Aftercare and maintenance: Patients keep their head upright for the first 4 hours, avoid massaging or rubbing the treated area, and avoid saunas and strenuous exercise for 7 days.
Managing Side Effects and Complications
- Brow or eyelid ptosis: occurs when toxin diffuses through the orbital septum into the levator palpebrae superioris, or when the frontalis is injected too low.
- Management: sympathomimetic eye drops (apraclonidine 0.5% or oxymetazoline) stimulate Müller's muscle to contract, temporarily lifting the lid by 1–2 mm while the toxin wears off.
- "Spock" eyebrow (Mephisto sign): the central frontalis is fully relaxed while the lateral part keeps pulling strongly.
- Management: an extra 1–2 U injected into the still-active lateral frontalis.
- Smile distortion / asymmetric mouth corner: caused by masseter toxin spreading into the risorius or the depressor anguli oris. The only remedy is to wait for the toxin to wear off (6–8 weeks).
- Toxin resistance (neutralizing antibodies): linked to very high doses or treatments spaced too closely (less than 2 months apart). It is managed by switching to a purified toxin free of complexing proteins (such as Xeomin) or extending the interval between treatments to more than 6 months.
